CMN News Alert Cantel Medical (CMN) 42.07 12/25/2014 11:03:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cantel Medical (CMN) 42.07 $CMN

Medical Supplier Steris Eyes Big Returns From Buyout
at Investor's Business Daily - Mon Dec 22, 1:30PM CST
Among IBD's 197 industry groups, one of the biggest movers lately is the Medical-Systems/Equipment group, which currently ranks No. 5 after sitting as low as No. 104 six months ago. The group has gotten a lift on a few different fronts, ranging from...
ISRG: 530.94 (+4.78), BDX: 139.90 (+1.44), STE: 66.76 (+0.85), CFN: 59.18 (+0.04), OMCL: 33.60 (+0.38), CMN: 42.07 (+0.40)

Cantel Medical Shares Up 14.2% Since SmarTrend's Buy Recommendation (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 9:53AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 14.17% as of today's recent price of $41.53.
CMN: 42.07 (+0.40)

Cantel Medical Earnings Review: 12 Days after Announcement Shares Down 7.7% (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 7:11AM CST
When Cantel Medical (NYSE:CMN) reported earnings a week ago on December 10th, 2014, analysts, on average, expected the company to report earnings of $0.27 on sales of $137.0 million. Cantel Medical actually reported earnings of $0.34 per share on sales of $136.8 million, beating EPS estimates by $0.07 and matching revenue estimates. Shares of Cantel Medical have slipped from $45.02 to $41.56, representing a loss of 7.7%, since the company reported earnings 12 days ago.
CMN: 42.07 (+0.40)

Sterilization Equipment and Supplies - 2014 Global Strategic Business Report: Growing Health Concerns Spur Demand
M2 - Thu Dec 18, 4:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/pcrkrm/sterilization) has announced the addition of the "Sterilization Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Sterilization Equipment and Supplies in US$ Million by the following Product Segments: - Filtration Sterilization - Heat Sterilization - Low Temperature Sterilization - Radiation Sterilization The report profiles 99 companies including many key and niche players such as: - 3M Company - Advanced Sterilization Products - Belimed AG - Cantel Medical Corp. - Cardinal Health, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers And Market Trends 3. End-Use Application Overview 4. Product Overview 5. Product Introductions And Launches 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 99 (including Divisions/Subsidiaries 114) - The United States (53) - Canada (5) - Japan (6) - Europe (39) - France (1) - Germany (13) - The United Kingdom (9) - Italy (7) - Spain (3) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (9) - Latin America (2) For more information visit http://www.researchandmarkets.com/research/pc...rilization
MMM: 166.96 (+0.09), CAH: 82.07 (+0.15), CMN: 42.07 (+0.40)

Uptrend Call Working As Cantel Medical Stock Rises 20.1% (CMN)
Comtex SmarTrend(R) - Mon Dec 15, 9:25AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 20.11% as of today's recent price of $43.69.
CMN: 42.07 (+0.40)

Cantel Medical's (CMN) CEO Andrew Krakauer on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Dec 10, 3:03PM CST

CMN: 42.07 (+0.40)

Cantel Med ups revenues 16% in FQ1
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 8:30AM CST

CMN: 42.07 (+0.40)

Cantel Medical misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 7:38AM CST

CMN: 42.07 (+0.40)

Cantel Medical Reports 16% Sales Growth And US GAAP EPS Of $0.27 For The First Quarter Ended October 31, 2014
PR Newswire - Wed Dec 10, 7:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) reported US GAAP net income of $11,239,000, or $0.27 per diluted share, inclusive of $0.03 of acquisition related (non-amortization of intangibles) charges on a 16% increase in sales to a record $136,811,000 for the first quarter ended October 31, 2014. This compares with net income of $11,185,000 or $0.27 per diluted share, on sales of $118,272,000 for the first quarter ended October 31, 2013.
CMN: 42.07 (+0.40)

Notable earnings before Wednesday's open
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 4:30PM CST

LAYN: 10.11 (+0.25), TITN: 13.96 (-0.31), COST: 143.65 (-0.50), VRA: 20.01 (-0.06), FRAN: 16.27 (-0.09), FGP: 23.06 (-0.16), LE: 54.28 (-0.30), TOL: 32.74 (+0.36), HOV: 4.02 (unch), CMN: 42.07 (+0.40)

Cantel Medical Corp. to Host First Quarter 2015 Earnings Conference Call and Webcast Live on Wednesday, December 10, 2014
ACCESSWIRE - Tue Dec 09, 3:06PM CST
LITTLE FALLS, NJ / ACCESSWIRE / December 9, 2014 / Cantel Medical Corp. (NYSE:CMN) will host a conference call and live webcast to discuss the results of the first quarter 2015, to be held Wednesday, December 10, 2014 at 11:00 AM Eastern Time.
CMN: 42.07 (+0.40)

Cantel Medical Shares Up 21.5% Since SmarTrend's Buy Recommendation (CMN)
Comtex SmarTrend(R) - Fri Dec 05, 4:58PM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 21.46% as of today's recent price of $44.18.
CMN: 42.07 (+0.40)

Laboratory Filtration Market 2014-2019 - Global Technology, Product, Accessories & End-User Forecasts for the $2.5 Billion Market
M2 - Fri Dec 05, 3:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/hmsvk6/laboratory) has announced the addition of the "Laboratory Filtration Market by Technology, Product, Accessories & by End-User - Global Forecasts to 2019" report to their offering. The global laboratory filtration market is expected to grow at a strong CAGR during the forecast period of 2014-2019 and is estimated to be worth $2,532.6 million by 2019. The market is mainly driven by the increasing research activities in the pharmaceutical and biotechnology segments, and growing demand for biotech molecules for therapeutic and diagnostic applications and increasing purity requirements in end-user markets. However, technological developments cutting down the use of the membrane filtration technology may hamper the growth of the market to a certain extent. During the forecast period the microfiltration segment will continue to dominate the laboratory filtration market. Microfiltration segment is growing primarily due to increasing use of microfiltration membranes as prefilters to ultrafiltration and reverse osmosis processes. Furthermore, growing demand of filtration technologies in pharmaceutical and biopharmaceutical industries is also expected to drive the growth of the laboratory filtration market. By 2019, North America will be the largest share to the global laboratory filtration market, followed by Europe, Asia-Pacific, and RoW. Developed markets like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia Pacific region is expected to have the fastest market growth during the forecast period, largely driven by the increasing research funding form government and private investors and growing number of research laboratories. The major players in the laboratory filtration market include The major players in the laboratory filtration market include Pall Corporation (U.S.), Merck Millipore (Germany), GE Healthcare (U.S.), Sartorius Group (Germany), 3M Purification (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Cantel Medical Corp. (U.S.), and Sigma Aldrich (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Laboratory Filtration Market, By Technology 8 Global Laboratory Filtration Equipment Market, By Type 9 Global Lab Filtration Accessories Market, By Type 10 Global Laboratory Filtration Market, By End User 11 Laboratory Filtration Market, By Geography 12 Competitive Landscape 13 Company Profiles - 3M Company - Cantel Medical Corp. - General Electric Company - Merck Millipore - Pall Corporation - Sartorius Group - Sigma-Aldrich Corporation - Sterlitech Corporation - Thermo Fisher Scientific, Inc. - Veolia Water Technologies Corporation For more information visit http://www.researchandmarkets.com/research/hmsvk6/laboratory
MMM: 166.96 (+0.09), GE: 25.83 (-0.05), PLL: 101.86 (+0.70), SIAL: 137.16 (-0.01), MRK: 57.46 (+0.25), CMN: 42.07 (+0.40)

Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its First Quarter Ended October 31, 2014
PR Newswire - Wed Dec 03, 2:00PM CST
CANTEL MEDICAL CORP. (NYSE:CMN) will release the results for its first quarter ended October 31, 2014 on Wednesday, December 10 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 42.07 (+0.40)

21.0% Return Seen to Date on SmarTrend Cantel Medical Call (CMN)
Comtex SmarTrend(R) - Fri Nov 28, 11:13AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 21.04% as of today's recent price of $44.03.
CMN: 42.07 (+0.40)

Dialysis Products and Services Market Report - Global Industry Analysis 2014-2020
M2 - Thu Nov 27, 2:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/55wbqr/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market. The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter's five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market. Report Scope Dialysis Products and Services Market, by Product type: - Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) - Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/55...s_products
NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), RMTI: 8.41 (-0.07), CMN: 42.07 (+0.40)

Cantel Medical To Present At The 26th Annual Piper Jaffray Healthcare Conference
PR Newswire - Thu Nov 20, 1:34PM CST
LITTLE FALLS, N.J., Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the 26th Annual Piper Jaffray Healthcare Conference at The New York Palace Hotel in New York. The formal presentation is scheduled for Tuesday, December 2, 2014 at 2:00 PM ET. In addition, Mr. Krakauer and Jorgen B. Hansen, President and COO, will be available for separate one-on-one meetings during the day.
CMN: 42.07 (+0.40)

12.9% Return Seen to Date on SmarTrend Cantel Medical Call (CMN)
Comtex SmarTrend(R) - Wed Nov 19, 5:08PM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 1 month, Cantel Medical has returned 12.91% as of today's recent price of $41.07.
CMN: 42.07 (+0.40)

Cantel Medical Corp. Names Jorgen Hansen as President and COO and Announces Other Corporate Appointments
PR Newswire - Mon Nov 17, 12:17PM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced the promotion of Jorgen Hansen, Executive Vice President and Chief Operating Officer, to President and Chief Operating Officer. Mr. Hansen joined Cantel in November 2012. Andrew Krakauer will remain Chief Executive Officer of Cantel.
CMN: 42.07 (+0.40)

Preventing Ebola? These 3 Healthcare Stocks Are Working On It
Todd Campbell, The Motley Fool - Motley Fool - Mon Nov 17, 11:35AM CST
A number of companies are working on vaccines that could help cure Ebola patients, but other companies that provide behind-the-scenes products and services might be better investments. Companies including Halyard Health   ,  Cantel Medical   ,...
HYH: 42.62 (-0.24), KMB: 117.77 (-0.21), SRCL: 133.27 (-0.16), CMN: 42.07 (+0.40)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 90

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 34

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 112

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Crypto: Brian Armstrong on Innovative Payment Solutions

Updated Category News Views 292

Coinbase's Vision for Payments in the Crypto World Brian Armstrong, the CEO of Coinbase Global Inc. (NASDAQ: COIN), is optimistic about the role of payments as a transformative use case within the cryptocurrency landscape. In a recent discussion, he articulated how he believes this sector will significantly evolve, particularly in terms of integrating stablecoins into...

Continue Reading
Veeva Basics Empowering Biotechs to Enhance Efficiency and Growth

Updated Category News Views 185

Veeva Basics Revolutionizes Biotech Operations In today's fast-paced biotech landscape, efficient operations are crucial. Veeva Systems (NYSE: VEEV) has introduced Veeva Basics, a solution now adopted by over 100 emerging biotechs. With this innovative approach, these companies can simplify and standardize their operations, allowing them to focus on what truly matters:...

Continue Reading
Exploring the Rise of Small-Cap Stocks: A 2024 Overview

Updated Category News Views 613

Small-Cap Stocks Lead 2024 Gains In the vibrant market of 2024, small-cap stocks have shined brighter than ever, showcasing remarkable performance that has left traditional blue-chip stocks in their wake. While larger, well-known companies often dominate discussions, smaller firms are making headlines with exhilarating returns. Remarkable Returns in the Market This year,...

Continue Reading
Ridge Street Capital Signs Significant Growth in Lending Sector

Updated Category News Views 206

Ridge Street Capital's Impressive Growth in Investment Lending Ridge Street Capital, a dynamic private lending firm, is celebrating a remarkable achievement in its operation, reporting over 150% growth from one year to the next. This impressive advancement marks the firm as a key player in investment property financing, primarily due to its tailored approach and...

Continue Reading
Kuehn Law Advocates for Sarepta Therapeutics Shareholders

Updated Category News Views 153

Kuehn Law Advocates for Sarepta Therapeutics Shareholders Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is reaching out to investors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) regarding pressing concerns that have surfaced about the company's internal practices. Recent investigations suggest that certain officers and directors possibly did not uphold...

Continue Reading